![](/img/cover-not-exists.png)
The cardiovascular outcomes, heart failure and kidney disease trials tell that the time to use Sodium Glucose Cotransporter 2 inhibitors is now
Johansen, Michael E., Argyropoulos, ChristosJournal:
Clinical Cardiology
DOI:
10.1002/clc.23508
Date:
November, 2020
File:
PDF, 5.45 MB
2020